It’s cheap, easy to make and in demand overseas. So why can’t this Texas-born COVID-19 vaccine break into the U.S. market?

It’s cheap, easy to make and in demand overseas. So why can’t this Texas-born COVID-19 vaccine break into the U.S. market?

A Houston vaccine team would like a U.S. distributor but for now focuses its efforts abroad to inoculate those in countries where COVID-19 variants surface more quickly. BY KAREN BROOKS HARPER The day before COVID-19 claimed its first Texas victim in 2020, Dr. Peter...

read more
Iceland Dumps Moderna COVID-19 Vaccine, While Finland & Norway Join Sweden and Denmark to Halt Use of mRNA-1273 in Young Population

Iceland Dumps Moderna COVID-19 Vaccine, While Finland & Norway Join Sweden and Denmark to Halt Use of mRNA-1273 in Young Population

Trial Site News is skeptical on Covid vaccines so we post selectively from their fact-based reports.  The fact that Scandinavian countries are taking the steps described below underscores the essentially variable meaning of "follow the science" in different countries...

read more
Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California

Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California

By Venice Servellita, et al. PREPrint ~ August 25, 2021 with Commentary from TrialSiteNews Below Abstract Associations between vaccine breakthrough cases and infection by SARS coronavirus 2 (SARS-CoV-2) variants have remained largely unexplored. Here we analyzed...

read more